Evanson Jeff
SEC CIK 1760511 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| OTLK | Outlook Therapeutics, Inc. | Chief Commercial Off | 808.5K | $73.4K | $500.1K | 4 | 2021-12-03 | 2024-03-07 |
Most active insiders at OTLK, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Sukhtian Ghiath M. | Dir, 10% | $7.50M | — |
| 2 | HILZINGER KURT J | Dir | $176.5K | — |
| 3 | Sukhtian Faisal Ghiath | Dir | $150.0K | — |
| 4 | Haddadin Yezan Munther | Dir | $39.1K | — |
| 5 | THURMAN RANDY H | Dir | $2,145 | — |
| 6 | Jahr Robert Charles | CEO, Dir | — | — |
| 7 | KENYON LAWRENCE A | CFO, Dir | — | — |
Evanson Jeff made no open-market trades at OTLK in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-11 | 2024-03-07 | OTLK | Outlook Therapeutics, Inc. | Evanson Jeff | Chief COMMERCIAL Off | P - Purchase | $0.42 | +62.5K | 808.5K | +8% | +$26.2K | |
| 2023-01-24 | 2023-01-20 | OTLK | Outlook Therapeutics, Inc. | Evanson Jeff | Chief Commercial Off | S - Sale | $1.11 | -267.0K | 746.0K | -26% | -$296.4K | |
| M | 2023-01-19 | 2023-01-17+ | OTLK | Outlook Therapeutics, Inc. | Evanson Jeff | Chief Commercial Off | S - Sale | $1.24 | -164.2K | 1.15M | -12% | -$203.7K |
| 2021-12-06 | 2021-12-03 | OTLK | Outlook Therapeutics, Inc. | Evanson Jeff | Chief Commercial Off | P - Purchase | $1.34 | +35.2K | 1.18M | +3% | +$47.2K |
Purchase Sale Sale after option exercise All abbreviations